Neonatal iNO therapy at low ppm is sensitive to small dosing inaccuracies. AERONOX 2.0 delivers mass flow-controlled NO with continuous side-stream monitoring (NO, NO₂, O₂), automatic NO₂-triggered safety response, and HFV compatibility – stable at the bedside and during transport.
Used for inhaled nitric oxide therapy in neonatal hypoxemic respiratory failure and persistent pulmonary hypertension of the newborn, at the bedside and during transport. Enables precise low-ppm delivery with continuous trigas monitoring and automatic NO₂ safety response during conventional and high-frequency ventilation.
For clinical evaluations, implementation support and product selection guidance..
SEND INQUIRY